| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10911091 | Lung Cancer | 2015 | 7 Pages |
Abstract
Patients with central and ultra-central lung tumors treated with SABR (50Â Gy in 4-5 fractions) experienced few toxicities and good outcomes, similar to patients with peripheral lung tumors.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Aadel A. Chaudhuri, Chad Tang, Michael S. Binkley, Michelle Jin, Jacob F. Wynne, Rie von Eyben, Wendy Y. Hara, Nicholas Trakul, Billy W. Jr., Maximilian Diehn,